Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v4-EN
Language French English
Date Updated 2019-01-10 2018-03-15
Drug Identification Number 02046202 02046202
Brand name LUTREPULSE LUTREPULSE
Common or Proper name LUTREPULSE LUTREPULSE
Company Name FERRING INC FERRING INC
Ingredients GONADORELIN ACETATE GONADORELIN ACETATE
Strength(s) 3.2MG 3.2MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 3 VIALS 3.2 MG LUTREPULSE FOR INJECTION 3 VIALS 3.2 MG LUTREPULSE FOR INJECTION
ATC code H01CA H01CA
ATC description HYPOTHALAMIC HORMONES HYPOTHALAMIC HORMONES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-03-28 2017-03-28
Actual start date 2017-03-28 2017-03-28
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments